Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Livestreamed Session
Livestreamed Session
Ticketed Session
Ticketed Session
Recorded Session
Recorded Session

  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    DG08--Tools for Your Practice: Updates & Resources for Genetic Counseling for CF & CRMS/CFSPID
    Location: 254 AB
    Chair: Sumedha Ghate, MS, CGC (she/her/hers) – St. Vincent Hospital - Medical Genetics
    Chair: Renee Temme, MS, CGC (she/her/hers) – Children's Minnesota - Medical Genetics
    Speaker: Chelsea Wagner, MS, CGC (she/her/hers) – BillionToOne
    Speaker: Angelique Mercier, MS CGC (she/her/hers) – Ann & Robert H. Lurie Children’s Hospital of Chicago
    Speaker: Denise M. Kay, Ph.D., PhD (she/her/hers) – New York State Newborn Screening Program, Wadsworth Center, New York State Department of Health
    CLIN
  • Thursday, Sep 26th
    7:45 AM – 9:45 AM ET
    DG10--Technology in Research
    Location: 162 AB
    Chair: Robert Fowler, MA, CCRC – Boston Children's Hospital
    Chair: Jonathan Greenberg, MA – Boston Children's Hospital
    Speaker: Emma J. McWilliams (she/her/hers) – Boston Children's Hospital
    Speaker: Dinesh Rai
    Speaker: Justin Anderson, MS, CCRC – University of Alabama at Birmingham
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02--Aging
    Location: Theater C (Exhibit & Poster Hall)
    Chair: Sophie Corriveau, MD, FRCPC – McMaster University
    Chair: Julian S. Tam, MD (he/him/his) – University of Saskatchewan
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.1- A single center cohort study evaluating the quality of colonoscopy bowel preparation in adults with cystic fibrosis
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Alexander G. Chen, MD – Rutgers Robert Wood Johnson Medical School
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.2- “How do you live the best life you can with this pain?”: A qualitative study of the challenges of living with CF and pain in the modulator era
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Deborah Friedman, PhD (she/her/hers) – Massachusetts General Hospital
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.4- Evaluation of the Danish colorectal cancer screening program among people with cystic fibrosis
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Karlen S. Bader-Larsen, MSc Human Nutrition (she/her/hers) – Department of Infectious Diseases, CF Center Copenhagen, Rigshospitalet, University of Copenhagen, Denmark
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.5- The lived experience of surviving to an older age with cystic fibrosis
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Janet E. Mitchell, MSc (she/her/hers) – Manchester University NHS Foundation Trust
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.6- No Stone Unturned: Utilizing Cross-sectional Imaging Studies to Assess Cardiovascular Risk in Cystic Fibrosis
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Roger Auth, MD (he/him/his) – Brown University
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.7- Changing and aging: Mental health complications in an evolving CF landscape
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Noma Abdulrahem, BSc (she/her/hers) – Cystic Fibrosis Canada
    CLIN
  • Thursday, Sep 26th
    9:00 AM – 9:50 AM ET
    RFPT02.8- Cardiovascular Risk Factors, ASCVD Risk Score, and Vascular Calcifications in Cystic Fibrosis Patients
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Pamela Barletta, MD,MS (she/her/hers) – University of Miami Hospital
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04--Advanced Lung Disease & Lung Transplant
    Location: 253 A-C
    Chair: Kathleen J. Ramos, MD MS (she/her/hers) – University of Washington
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07--Best Abstracts in GI & Hepatology
    Location: 207
    Chair: Tanja Gonska, MD – the Hospital for Sick Children
    Chair: Linda C. Cummings, MD, MS – University Hospitals Cleveland Medical Center/Case Western Reserve University
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11--Best Practice & Innovative Approaches in Clinical Research
    Location: 258 A-C
    Chair: Lisa Bendy, BA, CCRC – Indiana University
    Chair: Samantha K. Johnson (she/her/hers) – National Jewish Health
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13--Best Abstracts in Endocrinology
    Location: 104 AB
    Chair: Marissa Kilberg, MD, MSEd (she/her/hers) – Children's Hospital of Philadelphia
    Chair: Christine L. Chan, MD (she/her/hers) – University of Colorado
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04.1- Preferences of people with cystic fibrosis who have undergone a lung transplant
    Location: 253 A-C
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04.2- Use of Elexacaftor/Tezacaftor/Ivacaftor in Lung Transplant Recipients with Cystic Fibrosis in the US: a CFF Patient Registry Analysis
    Location: 253 A-C
    Speaker: Nora Burdis, MD (she/her/hers) – University of Washington
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04.3- Elexacaftor/tezacaftor/ivacaftor concentrations are similar between transplanted and non-transplanted people with CF
    Location: 253 A-C
    Speaker: Jennifer Guimbellot – Arkansas Children's Hospital/Arkansas Children's Research Institute
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04.4- Impact of Elexacaftor-Tezacaftor-Ivacaftor on the predicted 3-year risk of death or lung transplantation for individuals with advanced CF lung disease.
    Location: 253 A-C
    Speaker: Allison Love, MD, FRCPC – University of British Columbia
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W04.5- Advanced CF Lung Disease (ACFLD) in the CFFPR: Incidence of ACFLD and Characteristics of the ACFLD Population
    Location: 253 A-C
    Speaker: Jonathan V. Todd, PhD (he/him/his) – Cystic Fibrosis Foundation
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07.1- Evidence of protease dose-response in a Phase 1 trial of ANG003, a non-porcine pancreatic enzyme replacement therapy
    Location: 207
    Speaker: Drucy Borowitz, MD (she/her/hers) – State Univeristy at Buffalo Jacobs School of Medicine and Biomedical Sciences
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07.2- The Impact of CFTR Modulator Therapy on Acute Pancreatitis Frequency in Children with Acute Recurrent or Chronic Pancreatitis: A Report from INSPPIRE-2
    Location: 207
    Speaker: Gila C. Ginzburg, MD – Medical College of Wisconsin
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07.3- Intestinal complications in cystic fibrosis: Insights from F508del-Cftr mice on mucin dynamics and altered cellular functions
    Location: 207
    Speaker: Hailey Dodson – University of North Carolina at Chapel Hill
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07.4- Frequency of hepatobiliary abnormalities in young children with CF before and after 6 months of elexacaftor/tezacaftor/ivacaftor: Results from the BEGIN Study
    Location: 207
    Speaker: Nicole Green, MD (she/her/hers) – Pediatric Gastroenterology, Seattle Children's Hospital, Seattle, WA, USA
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W07.5- Elexacaftor, tezacaftor and ivacaftor (ETI) do not improve indices of hepatic fibrosis, liver stiffness or hepatic steatosis after 3 years, interim results of the PROMISE study.
    Location: 207
    Speaker: Michael R. Narkewicz, MD (he/him/his) – University of Colorado SOM and Children's Hospital Colorado
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11.1- Let’s get this straight: Building trust by clarifying expectations during first encounters at a new clinic
    Location: 258 A-C
    Speaker: Chandler Swope, LICSW (she/her/hers) – Cystic Fibrosis Foundation
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11.2- A QI Project to Reduce Clinic Visit Length and Improve Patient Communication
    Location: 258 A-C
    Speaker: Elena Bochicchio, PT, DPT, MBA (she/her/hers) – Yale New Haven Hospital
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11.3- Remotely addressing social risk factors (ELICIT) in cystic fibrosis: Design and implementation of a multicenter screening and intervention QI project
    Location: 258 A-C
    Speaker: Bryan Garcia, MD – UAB
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11.4- Enhancing the consistency and audit readiness of clinical research regulatory and subject binders
    Location: 258 A-C
    Speaker: Terri Visnick-Chang – UT Southwestern Medical Center
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W11.5- Enhancing data entry timeliness and quality in The Cystic Fibrosis Foundation Patient Registry: a quality improvement approach
    Location: 258 A-C
    Speaker: Daniel A. Diaz-Vigil – UC Davis School of Medicine
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13.1- Contraceptive use and pregnancy trends in the era of highly effective modulator therapy
    Location: 104 AB
    Presenting Author: Patricia A. Walker, MD (she/her/hers) – Lenox Hill Hospital Northwell Health
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13.2- Increased rates of maternal and neonatal complications in births among mothers with CF.
    Location: 104 AB
    Speaker: Stephanie Y. Cheng, MSc. (she/her/hers) – Cystic Fibrosis Canada
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13.3- Testicular Function and Fertility Outcomes in Male CF patients: A Single Center Retrospective Descriptive Study
    Location: 104 AB
    Speaker: Rossella Cannarella (she/her/hers) – Glikman Urological & Kidney Institute, Cleveland, Clinic, Cleveland, OH, USA
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13.4- The Effect of Omnipod 5 (OP5) Hybrid Closed Loop (HCL) Insulin Delivery on Glycemic Control in Adolescents and Adults with Cystic Fibrosis-Related Diabetes (CFRD)
    Location: 104 AB
    Speaker: Brynn E. Marks, MD, MSHPEd (she/her/hers) – Children's Hospital of Philadelphia
    CLIN
  • Thursday, Sep 26th
    10:15 AM – 12:15 PM ET
    W13.5- Single-center experience of effect of GLP-1 receptor agonists in adults with cystic fibrosis
    Location: 104 AB
    Speaker: Sanghoon Park, MD (he/him/his) – UT Southwestern
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04--Quality Improvement
    Location: Theater C (Exhibit & Poster Hall)
    Chair: Sophie Corriveau, MD, FRCPC – McMaster University
    Chair: Amy Dettori, MD (she/her/hers) – University of Washington / Seattle Children's Hospital
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.1- Development of a Standardized CF Reproductive Health Education Process at a Large Pediatric CF Care Center
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Justin Moss, CPhT (he/him/his) – Primary Children's Hospital
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.2- A quality improvement initiative improves timeliness of sweat test completion after referral for positive newborn screen at a large single center
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Jaclyn Davis, MD (she/her/hers) – Boston Children's Hospital
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.3- High Dose Vitamin D: Improving Vitamin D Deficiency and Identifying Barriers to Effective Therapy
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Jessica D'Amico, DO (she/her/hers) – Maine Medical Center
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.4- Screening for Cystic Fibrosis Associated Hepatobiliary Disease in a Pediatric and Adult Population
    Location: Theater C (Exhibit & Poster Hall)
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.5- Reduction of acid suppressor therapy in children with cystic fibrosis: A quality improvement initiative
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Ariel Berlinski, MD – University of Arkansas for Medical Sciences
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.6- Implementing a weight- inclusive approach to care in an adult cystic fibrosis clinic: a quality improvement project
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Alexis C. Wiggins, RDN (she/her/hers) – University of Virginia
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.7- Our patients asked and we listened: Increasing efficiency and decreasing total time of cystic fibrosis quarterly visits through quality improvement
    Location: Theater C (Exhibit & Poster Hall)
    Speaker: Stanford W. Chun, MD (he/him/his) – Children's Hospital Los Angeles
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 1:20 PM ET
    RFPT04.8- The quality improvement (QI) project aims to increase continuous insurance coverage for highly effective modulator therapy (HEMT)
    Location: Theater C (Exhibit & Poster Hall)
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    LL03--Prenatal & Postnatal Management of ETI Exposed Infants
    Location: 160 A-C
    Chair: Sylvia E. Szentpetery, MD (she/her/hers) – Medical University of South Carolina
    Chair: Aaron Trimble, MD – Oregon Health & Science University
    Speaker: Christopher Fortner, MD, PhD (he/him/his) – SUNY Upstate Medical University
    Speaker: Beth L. Pineles, MD, PhD (she/her/hers) – University of Pennsylvania
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT1-CLIN: PERT After Modulators
    Location: 204 B
    Facilitator: Vivek K. Shenoy, MD (he/him/his) – Emory/Children's Healthcare of Atlanta
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT2-CLIN: Constipation
    Location: 204 B
    Facilitator: Sujal Rangwalla, DO – Ascension Seton, Dell Children’s Medical Group
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT3-CLIN: Micronutrients
    Location: 204 B
    Facilitator: Asim Maqbool
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT4-CLIN: Chronic Pancreatitis
    Location: 204 B
    Facilitator: Elissa Downs – University of Minnesota
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT5-CLIN: Key to Successful Transition from the Pediatric to the Adult CF Program
    Location: 204 B
    Facilitator: Pi Chun (Jennifer) Cheng, MD, MS – Indiana University School of Medicine, Riley Hospital for Children
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT6-CLIN: Fetal CF Therapy
    Location: 204 B
    Facilitator: Ambika Shenoy, MD – Children's Hospital of Philadelphia
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT1-CLIN: Use of CGM in CFRD
    Location: 252 A
    Facilitator: Jennifer Apsan, MD – Northwell Health
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT2-CLIN: GI Cancers
    Location: 252 A
    Facilitator: Mitchell Ramsey, MD – The Ohio State University Wexner Medical Center
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT3-CLIN: Treatment of Overweight & Obesity in PwCF
    Location: 252 A
    CLIN
  • Thursday, Sep 26th
    12:30 PM – 2:00 PM ET
    RT4-CLIN: Ins & Outs of Tube Feeding
    Location: 252 A
    Facilitator: Jillian Sullivan, MD, MSCS – Larner College of Medicine at the University of Vermont
    CLIN
  • Thursday, Sep 26th
    1:30 PM – 2:20 PM ET
    FSC03--Fireside Chat with Toni Moran
    Location: Fireside Chat A (Exhibit & Poster Hall)
    Speaker: Toni Moran, MD (she/her/hers) – University of Minnesota
    Facilitator: Katherine Kutney – Case Western Reserve University
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03--Biomarkers of Infection & Inflammation
    Location: Theater A (Exhibit & Poster Hall)
    Chair: Scott Sagel, MD, PhD – Children's Hospital Colorado/University of Colorado Anschutz Medical Campus
    Chair: Christina S. Thornton, MD PhD – University of Calgary
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.1- Evidence for early reflux/aspiration as a trigger for the vicious cycle of CF airways disease that leads to bronchiectasis.
    Location: Theater A (Exhibit & Poster Hall)
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.2- Airway and systemic markers of inflammation associated with cystic fibrosis pulmonary exacerbation outcomes
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Valerie Waters, Toronto, Canada – The Hospital for Sick Children (SickKids)
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.3- The Stockholm Elexacaftor/Tezacaftor/Ivacaftor Task Force Study: Cohort description and identification of subgroups
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Terezia Pincikova, MD, PhD (she/her/hers) – Stockholm CF Center, Division of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.4- Plasma proteomics identifies changes in disease-associated pathways in subjects with CF bronchiectasis following Elexacaftor/Tezacaftor/Ivacaftor Initiation
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Emily J. Skala, BS – Cincinnati Children's Hospital
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.5- Specific Pseudomonas aeruginosa IgG levels before and after elexacaftor/tezacaftor/ivacaftor treatment
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Thomas Bryrup, MD (he/him/his) – Department of Infectious Diseases, Rigshospitalet
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.6- Siderophores as biomarkers for Pseudomonas aeruginosa infection in cystic fibrosis
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Pavel Drevinek, MD PhD (he/him/his) – Second Faculty of Medicine Charles University and Motol University Hospital
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.7- Detection of Nontuberculous Mycobacteria Disease Using Volatile Biomarkers
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Antao Gao, MS – University of British Columbia
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.8- Detection of Nontuberculous Mycobacteria Abscessus and Phage Treatment Response Using Volatile Biomarkers
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Antao Gao, MS – University of British Columbia
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.9- Longitudinal profiles of human breath reveal potential biomarkers for detecting and monitoring infections in cystic fibrosis during ivacaftor and antibiotic therapies
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Josephine Ackah-Cudjoe, MSc (she/her/hers) – University of British Columbia
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:00 PM ET
    TPS03.10- Development of a co-culture model for secondary screening of candidate anti-microbial compounds targeting persistent lung infections in cystic fibrosis.
    Location: Theater A (Exhibit & Poster Hall)
    Speaker: Hannah Donnelly, PhD (she/her/hers) – University of Dundee
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:30 PM ET
    S02--Paradigm Shift in CF Care Model
    Location: 253 A-C
    Chair: Rebekah F. Brown, MD (she/her/hers) – Vanderbilt University Medical Center
    Chair: Patrick A. Flume, MD – Medical University of South Carolina
    CLIN
  • Thursday, Sep 26th
    2:30 PM – 4:30 PM ET
    S05--An Evolving Understanding of ETI: Potential Mechanisms of Lingering Disease
    Location: 210 A-C
    Chair: Jerry A. Nick, MD (he/him/his) – National Jewish Health
    Chair: Jennifer Guimbellot – Arkansas Children's Hospital/Arkansas Children's Research Institute
    CLIN
  • Friday, Sep 27th
    7:45 AM – 9:45 AM ET
    DG15--Emerging Topics in CF Genetics & Genetic Counseling
    Location: 252 B
    Chair: Kathryn Singh, MPH, MS, CGC (she/her/hers) – University of California Irvine; Long Beach Memorial and Miller Children’s and Women’s Hospital
    Chair: Kimberly Foil, MS (she/her/hers) – Medical University of South Carolina
    Speaker: Karen Raraigh, MGC (she/her/hers) – Johns Hopkins University
    Speaker: Sylvia E. Szentpetery, MD (she/her/hers) – Medical University of South Carolina
    Speaker: Dan Dorgan, MD – University of Pennsylvania, Perelman School of Medicine
    CLIN
  • Friday, Sep 27th
    7:45 AM – 9:45 AM ET
    DG18--Explaining Research to New Populations
    Location: 254 AB
    Chair: Sarah Smith, BSN RN CCRC – Washington University in St. Louis
    Chair: Heather Y. Hathorne (she/her/hers) – University of Alabama at Birmingham
    Speaker: Maria del Carmen Reyes, MSN, NP (she/her/hers) – Children's Hospital Los Angeles
    Speaker: Sharon McNamara, MN (she/her/hers) – Seattle Children's Hospital
    Speaker: Jessica Hudson, MS, MPH – Cystic Fibrosis Foundation
    Speaker: Katie L. Howe, MS, CCRC (she/her/hers) – Cystic Fibrosis Foundation
    CLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07--Lung Image Analysis to Measure CF Lung Disease
    Location: Theater B (Exhibit & Poster Hall)
    Chair: Zackary I. Cleveland, PhD (he/him/his) – Cincinnati Children's Hospital Medical Center
    Chair: Daan Caudri, MD, PhD (he/him/his) – Erasmus MC - Sophia Children's Hospital
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.1- Revealing dynamic air-flow abnormalities with high-resolution lung MRI
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Zackary I. Cleveland, PhD (he/him/his) – Cincinnati Children's Hospital Medical Center
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.2- Evaluation of Pulmonary Ventilation and Perfusion in Cystic Fibrosis Lung Disease using Functional Proton and Hyperpolarized Xe Magnetic Resonance Imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Samal Munidasa – Cincinnati Childrens Hospital
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.3- Establishing a magnitude-independent minimum clinically important difference of hyperpolarized xenon-129 magnetic resonance ventilation imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Vanessa M. Diamond, MSc (she/her/hers) – University of British Columbia
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.4- Determining the cross-platform interoperability of 129Xe ventilation MRI: Implications for multi-center clinical trials
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Rachel L. Eddy, PhD (she/her/hers) – University of British Columbia
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.5- Early Cystic Fibrosis Lung Disease Progression by Multiple-Breath Washout and Chest Magnetic Resonance Imaging
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Eva Steinke, MD (she/her/hers) – Department of Pediatric Respiratory Medicine, Immunology and Critical Care Medicine, Charité-Universitätsmedizin Berlin, Germany
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.6- Longitudinal Evaluation of the Responsiveness of Hyperpolarized 129Xe Multiple-Breath Washout MRI to Elexacaftor/Tezacaftor/Ivacaftor Treatment in Pediatric Cystic Fibrosis
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Faiyza S. Alam (she/her/hers) – University of Toronto
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.7- Elexacaftor/tezacaftor/ivacaftor therapy improves lung clearance Index and magnetic resonance imaging scores in children with cystic fibrosis and one or two F508del alleles
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Mirjam Stahl, MD (she/her/hers) – Charité Universitätsmedizin, Berlin, Germany
    APPTTCLIN
  • Friday, Sep 27th
    9:00 AM – 9:50 AM ET
    RFPT07.8- ‘Silent' progression of lung disease in people receiving ETI therapy revealed by Oxygen Enhanced-MRI (OE-MRI)
    Location: Theater B (Exhibit & Poster Hall)
    Speaker: Christopher Short, MRes – Imperial College London
    APPTTCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19--Remote Monitoring
    Location: 253 A-C
    Chair: Jordana Hoppe, MD (she/her/hers) – University of Colorado
    Chair: Jaclyn Davis, MD (she/her/hers) – Boston Children's Hospital
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22--Lungs & Beyond
    Location: 258 A-C
    Chair: Allison Love, MD, FRCPC – University of British Columbia
    Chair: Sid G. Kapnadak, MD (he/him/his) – University of Washington School of Medicine
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25--Cutting-Edge Research: What's New?
    Location: 210 A-C
    Chair: Gina Hong, M.D., M.H.S. – University of Pennsylvania Perelman School of Medicine
    Chair: Don B. Sanders, MD, MS – Indiana University School of Medicine
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26--I Have a Gut Feeling
    Location: 104 AB
    Chair: Dhiren Patel, MD (he/him/his) – Saint Louis University
    Chair: Jay Freeman, MD, MSc (he/him/his) – Nationwide Children's Hospital
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29--The Power of Data to Impact Patients, Policy, & Population
    Location: 205 A-C
    Chair: Edward McKone – School of Medicine, University College Dublin, Ireland
    Chair: Anna V. Faino, MSc (she/her/hers) – Seattle Children's Research Institute
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19.1- Improving Clinical Use of Pediatric home Spirometry – The ICUPS Project
    Location: 253 A-C
    Speaker: Clement L. Ren, MD, MBA (he/him/his) – Children’s Hospital Of Philadelphia
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19.2- Assessing readiness to the early implementation of self-obtained respiratory cultures for patients with cystic fibrosis
    Location: 253 A-C
    Speaker: Andrew Paisley, MD (he/him/his) – Cincinnati Children's Hospital Medical Center
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19.3- Remote social needs screening and intervention: Early results and lessons learned from implementation of the ELICIT study at two large pediatric CF centers
    Location: 253 A-C
    Speaker: Moira Harrison, LICSW (she/her/hers) – Boston Children's Hospital
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19.4- Innovations for home spirometry implementation in youth with cystic fibrosis: Interim results from a multicenter quality improvement initiative
    Location: 253 A-C
    Speaker: Thida Ong, MD (she/her/hers) – Seattle Children's Hospital/UW
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W19.5- Expanded Use of Remote Objective Monitoring During Telehealth Visits for People with CF Experiencing Acute Symptoms: The EUROPA Study
    Location: 253 A-C
    Speaker: William R. Hunt, MD (he/him/his) – Emory Univeristy
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22.1- Adherence to Elexacaftor/Tezacaftor/Ivacaftor and clinical outcomes in People with Cystic Fibrosis (CF) – the RECOVER Study
    Location: 258 A-C
    Speaker: Paul McNally – RCSI University of Medicine and Health Sciences
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22.2- Effect of Elexacaftor-Tezacaftor-Ivacaftor on Long-Term Lung Function and BMI Trajectories
    Location: 258 A-C
    Speaker: George M. Solomon, MD – University of Alabama at Birmingham, Birmingham, AL USA
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22.3- Liver disease outcomes in people with CF after two years of Elexacaftor/Tezacaftor/Ivacaftor – Results from the RECOVER trial
    Location: 258 A-C
    Speaker: Paul McNally – RCSI University of Medicine and Health Sciences
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22.4- Triple CFTR modulator combination improves glucose tolerance in adolescents with cystic fibrosis. Data from the French observational pediatric study MODUL-CF
    Location: 258 A-C
    Speaker: Alfonso Galderisi, MD, PhD (he/him/his) – Yale University, Department of pediatrics, New Haven, CT, United States
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W22.5- Maternal and fetal outcomes in the era of CFTR modulators (MAYFLOWERS) study: interim results
    Location: 258 A-C
    Speaker: Raksha Jain, MD, MSc (she/her/hers) – University of Texas Southwestern Medical Center
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25.1- Vanzacaftor/Tezacaftor/Deutivacaftor (VNZ Triple) in Adolescents and Adults with CF: Results from Two Randomized, Active-Controlled Phase 3 Trials
    Location: 210 A-C
    Speaker: Claire Keating, MD – Columbia University Irving Medical Center
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25.2- Quantification of Elexacaftor/Tezacaftor/Ivacaftor levels: Comparison between the STEADY Study validation cohort and real world experience
    Location: 210 A-C
    Speaker: Silvia Caceres – National Jewish Health
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25.3- Long-term effects of elexacaftor/tezacaftor/ivacaftor therapy on airway and systemic inflammation in CF
    Location: 210 A-C
    Speaker: Scott Sagel, MD, PhD – Children's Hospital Colorado/University of Colorado Anschutz Medical Campus
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25.4- Lung Function and Pulmonary Exacerbations in Individuals who Discontinue Chronic Daily Respiratory Therapies: Results of the HERO-2 Study
    Location: 210 A-C
    Speaker: Cynthia Brown, MD, MS (she/her/hers) – Indiana University
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W25.5- Home Spirometry as a CF Clinical Trial Endpoint: Results of the OUTREACH Study
    Location: 210 A-C
    Speaker: Margaret Rosenfeld, MD, MPH (she/her/hers) – University of Washington
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.1- Elexacaftor/Tezacaftor/Ivacaftor on Gastrointestinal pH and Motility in CF Adults: Results from PROMISE
    Location: 104 AB
    Speaker: Zachary M. Sellers, MD, PhD – Stanford University
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.2- Improvement in abdominal symptoms (CFAbd-Score) and gut inflammation over 12 months of treatment with Elexacaftor/Tezacaftor/Ivacaftor in children with CF aged 6-11– results from the RECOVER study
    Location: 104 AB
    Speaker: Jane C. Davies, MD MBChB MRCP FMedSci (she/her/hers) – National Heart and Lung Institute, Imperial College London
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.3- The relationship of the CF metabolome to treatment response following CFTR rescue
    Location: 104 AB
    Speaker: Mimi Saavedra, MD – National Jewish Health
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.4- Gastrointestinal pathologies in pediatric cystic fibrosis patients undergoing endoscopy: A single center retrospective review
    Location: 104 AB
    Speaker: Jacob O. Robson, MD, MS (he/him/his) – University of Utah
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W26.5- A Multi-center Study of Non-invasive Colorectal Cancer Evaluation in Cystic Fibrosis (NICE-CF)
    Location: 104 AB
    Speaker: Christine Hachem, MD (she/her/hers) – Saint Louis University
    EPPCLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29.1- Cystic fibrosis mortality trends in countries where people cannot access Elexacaftor/Tezacaftor/Ivacaftor therapy
    Location: 205 A-C
    Speaker: Gianfranco Alicandro, PhD (he/him/his) – Università degli Studi di Milano, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29.2- Real world impact of elexacaftor/tezacaftor/ivacaftor on pulmonary and nutritional outcomes in people with cystic fibrosis
    Location: 205 A-C
    Speaker: Georgene E. Hergenroeder, MD (she/her/hers) – Children's Hospital of Philadelphia, Division of Pulmonary and Sleep Medicine
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29.3- Utility of sweat sodium to chloride ratio for diagnosis of CFTR-RD and CRMS
    Location: 205 A-C
    Speaker: Angela Metcalf, MD (she/her/hers) – University of Colorado
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29.4- Association of Change in Respiratory Infection After ETI Therapy on Clinical Outcomes
    Location: 205 A-C
    Speaker: Mordechai Pollak, MD, MSc (he/him/his) – Pediatric Pulmonology Institute, Schneider Children's Medical Center of Israel, Petach Tikva, Israel
    CLIN
  • Friday, Sep 27th
    10:15 AM – 12:15 PM ET
    W29.5- Increasing incidence of cardiac discharges and cardiovascular comorbidities amongst cystic fibrosis hospitalizations: 2012-2020
    Location: 205 A-C
    Speaker: Joel Mintz, MD, MS – University of Miami/Jackson Memorial Hospital
    CLIN
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S13--Hepatology Implementation of the New Liver Guidelines
    Location: 253 A-C
    Chair: David N. Assis, MD – Yale School of Medicine
    Chair: Amanda C. Fifi, MD (she/her/hers) – University of Miami
    CLIN
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S16--Year(s) in Review
    Location: 258 A-C
    Chair: Pierre-Régis Burgel, MD, PhD (he/him/his) – Assistance Publique Hopitaux de Paris and Université de Paris
    Chair: Ranjani Somayaji, MD, MPH, FRCPC (she/her/hers) – University of Calgary
    CLIN
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S19--Demystifying CF Bone Disease: From Pathophysiology to Treatment
    Location: 206 AB
    Chair: Vin Tangpricha, MD, PhD – Emory University School of Medicine
    Chair: Malinda Wu, MD, MSCR (she/her/hers) – Johns Hopkins University School of Medicine
    CLIN
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S22--Finding an “Optimal” Dose in Drug Development: The Importance of Exposure/Response Relationships for Advancing Chronic CF Therapies
    Location: 210 A-C
    Chair: Donald R. VanDevanter, PhD – Case Western Reserve University School of Medicine
    Chair: Nicole Mayer Hamblett, PhD (she/her/hers) – University of Washington
    APPTTCLINPHARMPTAC/CFTR
  • Friday, Sep 27th
    2:30 PM – 4:30 PM ET
    S23--Updates in CFTR Genetics
    Location: 109 AB
    Chair: Johanna Rommens, PhD – SickKids Research Institute
    Chair: Samantha Afonso, MS, CGC, CCGC (she/her/hers) – Adult CF Clinic, St. Michael's Hospital, Unity Health Toronto
    CLIN
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    DG23--Pancreatic Prowess: Navigating CF, Liver Wellness, & Nutritional Implications
    Location: 160 A-C
    Chair: Maegan Cook, MS, RD, LD, CNSC – Children's Healthcare of Atlanta
    Chair: Christina Chadwick, MD – University of Florida
    Speaker: Megha Mehta, MD (she/her/hers) – UT Southwestern Medical Center
    Speaker: Kimberly G. Stephenson, MS, RD, CSP, CACFD (she/her/hers) – University of North Carolina Health
    Speaker: Jay Freeman, MD, MSc (he/him/his) – Nationwide Children's Hospital
    Speaker: Thomas J. Sferra, MD (he/him/his) – UH Rainbow Babies and Children's Hospital / Case Western Reserve University
    NTRCLIN
  • Saturday, Sep 28th
    7:45 AM – 9:45 AM ET
    DG25--RC Updates & Special Topics
    Location: 254 AB
    Chair: Patricia Burks, RN, MA, CCRC – Cystic Fibrosis Foundation
    Chair: Adrienne DeRicco, BSN, RN, CCRC (she/her/hers) – UPMC Children's Hospital of Pittsburgh
    Speaker: Margret Powell, CCRC (she/her/hers) – UNC School of Medicine
    Speaker: Megan Devereaux, CCRC (she/her/hers) – University of Wisconsin - Madison
    Speaker: Dana Coyle
    Speaker: Jordana Hoppe, MD (she/her/hers) – University of Colorado
    CLIN
  • Saturday, Sep 28th
    8:00 AM – 9:15 AM ET
    CC03--Advanced QI
    Location: 210 A-C
    Chair: Anna K. Saulitis, AM, LCSW (she/her/hers) – Cystic Fibrosis Foundation
    Chair: Lauren Mitchell, PT, DPT (she/her/hers) – Cystic Fibrosis Foundation
    CLIN
  • Saturday, Sep 28th
    8:00 AM – 9:15 AM ET
    CC05--Diagnostic & Counseling Challenges
    Location: 253 A-C
    Chair: Karen Raraigh, MGC (she/her/hers) – Johns Hopkins University
    Chair: Michael Smiley, MD (he/him/his) – Department of Pediatrics, Cardinal Glennon Children's Hospital, Saint Louis University School of Medicine
    CLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    S26--From Just Surviving to Thriving: Unraveling the Complex Tapestry of CF & Aging
    Location: 210 A-C
    Chair: Stefanie Krick, MD PhD – Division of Pulmonary and Critical Care Medicine
    Chair: Elizabeth Tullis, MD FRCPC – University of Toronto
    CLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    S29--It Starts with a Diagnosis, Best Practices for Newborn Screening
    Location: 253 A-C
    Chair: Susanna A. McColley, MD, FAAP, ATSF (she/her/hers) – Northwestern University Feinberg School of Medicine
    Chair: Marci K. Sontag, PhD (she/her/hers) – Center for Public Health Innovation
    CLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36--Endocrine Screening - What You Need to Know
    Location: 104 AB
    Chair: Mary Sachs, MSN, APRN, CNP (she/her/hers) – Children's Minnesota
    NRSCLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36.1- Significant impact of menopause transition in UK females with cystic fibrosis (fwCF): a large-centre study in the highly effective modulator therapy (HEMT) era
    Location: 104 AB
    Speaker: Ladina Weitnauer, MD (she/her/hers) – Royal Brompton Hospital, London, UK
    NRSCLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36.2- Longitudinal changes in bone mineral density in adolescents and adults with cystic fibrosis on elexacaftor/tezacaftor/ivacaftor – results from the PROMISE study
    Location: 104 AB
    Speaker: Meghan Shirley Bezerra, PhD (she/her/hers) – Children's Hospital of Philadelphia
    NRSCLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36.3- Innovative Quality Improvement intervention to improve CF bone disease detection: a single center’s experience
    Location: 104 AB
    Speaker: Farah Abu Dhais, MD, MRCPCH (she/her/hers) – Corewell health
    NRSCLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36.4- Feasibility of using continuous glucose monitoring to detect glycemic abnormalities in children with CF.
    Location: 104 AB
    Speaker: Amanda R. Leonard, MPH, RDN, LDN, CDCES (she/her/hers) – Johns Hopkins Hospital
    NRSCLIN
  • Saturday, Sep 28th
    10:15 AM – 12:15 PM ET
    W36.5- Performance of HbA1c for CFRD Screening: Analysis of US CF Foundation Patient Registry Data
    Location: 104 AB
    Speaker: Monique D. Maher, MD (she/her/hers) – University of Colorado, Anschutz Medical Campus
    NRSCLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    LL09--Site Collaboration
    Location: 259 AB
    Chair: Julia Giancola, MSN, RN, CPN, CCRC (she/her/hers) – Boston Children's Hospital
    Chair: Alix Wilson – National Jewish Health
    Community Speaker: Steph Hansen (she/her or they/them) – Patient Advocate
    Speaker: Salma Moreno (she/her/hers) – National Jewish Health
    Speaker: Rachel Rich, CCRC – Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    LL14--Highs & Lows of GI & Endocrine
    Location: 160 A-C
    Chair: Marina Litvin, MD – Washington University School of Medicine in St. Louis
    Chair: Megan Gabel, MD – University of Rochester, Golisano Children's Hospital
    Speaker: Jessica K. Groshong, RD,LD – Washington University School of Medicine Adult Cystic Fibrosis Clinic
    Speaker: Marina Litvin, MD – Washington University School of Medicine in St. Louis
    Speaker: Megan Gabel, MD – University of Rochester, Golisano Children's Hospital
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT3-CLIN: From Bedside to Bench to Redcap: The Role of the Research Coordinator in Translational Research
    Location: 204 B
    Facilitator: Silvia Caceres – National Jewish Health
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT4-CLIN: Phage Therapy in 2024: Clinical Trials or Compassionate Care- What Are the Options Now?
    Location: 204 B
    Facilitator: Jonathan L. Koff – Yale University
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT5-CLIN: LGBTQIA+ Participants in Research
    Location: 204 B
    Facilitator: Catherine S. Larson, BS/RRT/CCRC (she/her/hers) – University of Minnesota
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT6-CLIN: I'm a Research Manager, Now What?
    Location: 204 B
    Facilitator: Sharon McNamara, MN (she/her/hers) – Seattle Children's Hospital
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT7-CLIN: PI Oversite
    Location: 204 B
    Facilitator: Allison Messuri-Swan, RN (she/her/hers) – Boston Children's Hospital
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT8-CLIN: Mental Health for RCs & Patients
    Location: 204 B
    Facilitator: Margret Powell, CCRC (she/her/hers) – UNC School of Medicine
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT2-CLIN: Improving OGTT Rates
    Location: 251
    Facilitator: Jeralyn Wunderley, MHA, BSN, RN, CCM (she/her/hers) – Medical University of South Carolina
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT3-CLIN: Diabetes Technology
    Location: 251
    Facilitator: Brynn E. Marks, MD, MSHPEd (she/her/hers) – Children's Hospital of Philadelphia
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT4-CLIN: Diabetes Post-transplant
    Location: 251
    Facilitator: Henry Zelada, MD (he/him/his) – UCLA
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT1-CLIN: It's Not so Scary! How to Make the Most of Your Program Site Visit
    Location: 252 A
    Facilitator: John Schuen, MD (he/him/his) – Corewell Health
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT2-CLIN: Help Wanted! How to Manage Staff Turnover
    Location: 252 A
    Facilitator: Cathy Chacon, RN
    CLIN
  • Saturday, Sep 28th
    12:30 PM – 2:00 PM ET
    RT3-CLIN: Severe Vitamin Deficiencies: What to Do When Oral Replacement Fails?
    Location: 252 A
    Facilitator: Nicole Borroff, RDN (she/her/hers) – National Jewish Health
    CLIN